| Price | 5.15 |
| Price Change Today | -$0.05 (-0.96%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $5.20 |
| Previous Close | $5.20 |
| Daily Range | $5.05 - $5.20 |
| 52-Week Range | $3.15 - $6.69 |
| Volume | 63,458 |
| Oncolytics Biotech, Inc. focuses on the discovery and development of pharmaceutical products for the treatment of a wide variety of human and companion pet cancers. The Company was formed to explore the oncolytic capability of the reovirus, a virus that preferentially replicates in cells with an activated Ras pathway, one of the most common family of genetic defects leading to cancer. | |





Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment